MCP4

MCP4 is a bradyzoite-specific cyst wall protein of Toxoplasma gondii that contributes to the protein architecture of the tissue cyst wall during chronic-stage differentiation (PMID:31040239). It physically associates with the bradyzoite pseudokinase BPK1 within the cyst wall complex, marking it as a member of this wall-associated assembly (PMID:23291621). Its stage-restricted expression is enforced transcriptionally: the ApiAP2 factor AP2IV-4 represses MCP4 in tachyzoites, and loss of AP2IV-4 causes ectopic MCP4 expression in replicating tachyzoites, placing AP2IV-4 upstream of MCP4 in the regulatory hierarchy governing bradyzoite differentiation (PMID:29718996). Beyond its cyst wall localization, its BPK1 association, and its AP2IV-4-dependent repression, no biochemical activity or structural function for MCP4 has been characterized in the available corpus.

1. 2013 Medium

   To define the molecular composition of the bradyzoite cyst wall complex, MCP4 was identified as a physical partner of the pseudokinase BPK1, establishing it as a member of a wall-associated protein assembly rather than a free-standing factor.

   Evidence Immunoprecipitation of BPK1 from in vitro bradyzoite cultures with protein identification

   PMID:23291621

   Open questions at the time

   • Single Co-IP without reciprocal pull-down or orthogonal validation of the MCP4-BPK1 interaction
   • The functional consequence of the MCP4-BPK1 association is undefined
   • Whether the interaction is direct or bridged by other cyst wall components is unknown
2. 2018 Medium

   To understand how MCP4's bradyzoite-restricted expression is controlled, the ApiAP2 factor AP2IV-4 was shown to repress MCP4 in tachyzoites, placing a specific transcriptional regulator upstream of this cyst wall component in the differentiation program.

   Evidence AP2IV-4 genetic knockout with immunological detection of ectopic MCP4 in tachyzoites, validated in a murine model

   PMID:29718996

   Open questions at the time

   • Whether AP2IV-4 binds the MCP4 locus directly or acts indirectly is not resolved
   • The activating factors that drive MCP4 expression in bona fide bradyzoites are not identified
3. 2019 Medium

   To confirm MCP4's subcellular assignment, proteomic analysis of a purified cyst wall fraction independently placed MCP4 in the cyst wall, corroborating its role as a structural constituent of this compartment.

   Evidence Percoll gradient enrichment and CST1 immunoprecipitation of the cyst wall followed by LC-MS/MS

   PMID:31040239

   Open questions at the time

   • Localization not independently validated for MCP4 specifically (e.g. by tagging or microscopy) in this study
   • The contribution of MCP4 to cyst wall integrity or persistence is untested

• The biochemical activity and structural function of MCP4 within the cyst wall, and the mechanism by which it engages BPK1 and other wall components, remain unknown.
• No loss-of-function phenotype for MCP4 itself has been reported
• No structural model or biochemical activity is defined
• Whether MCP4 is required for cyst wall formation or bradyzoite persistence is untested